Objectives: The relationship between inflammatory bowel disease (IBD) and cancer remains
unclear especially in Asian populations. Therefore, we conducted a nationwide population …

Background Data on real-life patterns of biologic use for inflammatory bowel disease (IBD)
are scarce. Aims We aimed to examine the patterns of biologic use and the factors …

Inflammatory bowel disease (IBD) is a chronic relapsing intestinal inflammatory disorder with
unidentified causes. Currently, studies indicate that IBD results from a complex interplay …

The inflammatory bowel diseases [IBDs], inclusive of Crohn's disease [CD] and ulcerative
colitis [UC], are chronic, progressive immune-mediated diseases associated with high …

Methods During the induction phase (doses at day 1, 15), clinical remission, enhanced
clinical response, and change in C-reactive protein at 6 weeks; during the maintenance …

Background and Aims: Efficacy of adalimumab in Crohn's disease (CD) has not been shown
in China. The aim of this study was to evaluate the efficacy and safety of adalimumab in …

Intestinal bacteria coexist with humans and play a role in suppressing the invasion of
pathogens, producing short-chain fatty acids, producing vitamins, and controlling the …

Immune checkpoint inhibitors (ICIs) such as cytotoxic T-lymphocyte-associated protein 4
(CTLA-4), programmed cell death protein 1 (PD-1) and programmed cell death protein …

Background Polymorphisms in immunity-related GTPase family M (IRGM) gene may be
associated with inflammatory bowel disease (IBD) by affecting autophagy. However, the …

Background Canadian-born children of South Asian [SA] ethnicity develop inflammatory
bowel disease [IBD] at similar rates to those among Caucasian children. We evaluated the …